A Method for Monitoring Red Cell Engraftment Post Bone‐Marrow Transplant in Sickle Cell Disease

ABSTRACT Allogenic bone marrow transplant (BMT) is a proven curative treatment for sickle cell disease (SCD). Individuals undergoing BMT are monitored using chimerism assays to assess donor cell engraftment. This assay does not reflect engraftment of erythrocytes, which are the essential cell types required to cure SCD. We present a droplet digital PCR (ddPCR) assay capable of detecting reticulocyte‐derived β‐globin RNA alleles (β A and β S ) from whole blood. As globin RNA is specific to red cells, restricted to reticulocytes and not present in erythrocytes, and is in high abundance, it is the ideal biomarker to monitor donor engraftment. Sickle cell disease patients (HbSS) do not have any healthy β A ‐globins and therefore any β A transcript detected must be donor derived. We compared globin allele detection in whole blood and CD71 + reticulocytes isolated from the same samples and found no significant difference in assay performance (correlation r 2 > 0.9). Therefore, removing the need to isolate reticulocytes saved time and associated costs, making it better suited to diagnostic services. The assay can be used from day 0 but in successful transplants it is informative from day 6 post‐transplant. Transfused blood contains reticulocytes and the target allele (β A ‐globin RNA). Transfusions therefore interfere with transplant monitoring, but the interference is short‐lived, being cleared in 2 days. We demonstrate that ddPCR is a simple and effective method for monitoring red cell engraftment in the first 3 weeks post‐transplant.

Authors

Institutions

Publication Details

Journal
International Journal of Laboratory Hematology
Published
2026-11-17
DOI
https://doi.org/10.1111/ijlh.70282
Primary Topic
Hemoglobinopathies and Related Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

A Method for Monitoring Red Cell Engraftment Post Bone‐Marrow Transplant in Sickle Cell Disease

Claire E. Laas, Frances Brown, Subarna Chakravorty, Aytug Kizilors et al.
1 links
International Journal of Laboratory Hematology
Hemoglobinopathies and Related Disorders
article

A Method for Monitoring Red Cell Engraftment Post Bone‐Marrow Transplant in Sickle Cell Disease

Claire E. Laas, Frances Brown, Subarna Chakravorty, Aytug Kizilors, Fahimi Alireza, Barnaby E. Clark, Najeem I. Folarin, Rachel S. Carling, Azalea A. Khan, Nicholas C. Lea, Kar Lok Kong, Ifeyinwa Eze, Woldu A. Hambir
article en

Abstract

ABSTRACT Allogenic bone marrow transplant (BMT) is a proven curative treatment for sickle cell disease (SCD). Individuals undergoing BMT are monitored using chimerism assays to assess donor cell engraftment. This assay does not reflect engraftment of erythrocytes, which are the essential cell types required to cure SCD. We present a droplet digital PCR (ddPCR) assay capable of detecting reticulocyte‐derived β‐globin RNA alleles (β A and β S ) from whole blood. As globin RNA is specific to red cells, restricted to reticulocytes and not present in erythrocytes, and is in high abundance, it is the ideal biomarker to monitor donor engraftment. Sickle cell disease patients (HbSS) do not have any healthy β A ‐globins and therefore any β A transcript detected must be donor derived. We compared globin allele detection in whole blood and CD71 + reticulocytes isolated from the same samples and found no significant difference in assay performance (correlation r 2 > 0.9). Therefore, removing the need to isolate reticulocytes saved time and associated costs, making it better suited to diagnostic services. The assay can be used from day 0 but in successful transplants it is informative from day 6 post‐transplant. Transfused blood contains reticulocytes and the target allele (β A ‐globin RNA). Transfusions therefore interfere with transplant monitoring, but the interference is short‐lived, being cleared in 2 days. We demonstrate that ddPCR is a simple and effective method for monitoring red cell engraftment in the first 3 weeks post‐transplant.

International Journal of Laboratory Hematology
King's College Hospital (GB)
Good health and well-being
Hemoglobinopathies and Related Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon